MME
CELG

Meag Munich Ergo’s Celgene Corp CELG Stock Holding History

Meag Munich Ergo’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-46,447
Closed -$4.57M – 532
2019
Q3 		$4.57M Buy
46,447
+20,181
+77% +$1.92M 0.24% 100
2019
Q2 		$2.43M Hold
26,266
– – 0.19% 116
2019
Q1 		$2.3M Sell
26,266
-44,636
-63% -$3.9M 0.19% 120
2018
Q4 		$4.47M Hold
70,902
– – 0.55% 46
2018
Q3 		$6.29M Buy
70,902
+31,690
+81% +$2.8M 0.37% 83
2018
Q2 		$3.03M Buy
39,212
+5,176
+15% +$430K 0.19% 163
2018
Q1 		$3M Sell
34,036
-51,152
-60% -$4.91M 0.12% 225
2017
Q4 		$8.98M Buy
85,188
+63,084
+285% +$7.12M 0.35% 79
2017
Q3 		$3.17M Buy
22,104
+222
+1% +$30.2K 0.13% 172
2017
Q2 		$2.88M Buy
+21,882
New +$2.68M 0.13% 182
2015
Q3 		– Sell
-30,398
Closed -$3.5M – 279
2015
Q2 		$3.5M Buy
+30,398
New +$3.48M 0.18% 130
2015
Q1 		– Sell
-31,255
Closed -$3.55M – 229
2014
Q4 		$3.55M Buy
+31,255
New +$3.3M 0.16% 150
2014
Q3 		– Sell
-239,292
Closed -$20.6M – 257
2014
Q2 		$20.6M Buy
+239,292
New +$18.2M 0.9% 35

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Meag Munich Ergo's CELG Position: Q4 2019 in Review

Meag Munich Ergo sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 46,447 shares — an estimated $4.57M sold.

Meag Munich Ergo first reported a position in CELG in Q2 2014 and held it in 13 quarters. The position peaked at $20.6M in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Meag Munich Ergo reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Meag Munich Ergo sold 46,447 Celgene Corp shares in Q4 2019, an estimated $4.57M.
  • Meag Munich Ergo first reported a position in Celgene Corp in Q2 2014 and held it in 13 quarters.
  • Meag Munich Ergo's Celgene Corp position peaked at $20.6M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Meag Munich Ergo's 13F filing for Q4 2019, filed 17 Jan 2020.